세계의 m-RNA 합성 서비스 시장 보고서(2025년)

A messenger ribonucleic acid (mRNA) synthesis service involves the production of custom mRNA molecules through in vitro transcription using a provided deoxyribonucleic acid (DNA) template. These services are utilized for various purposes, including vaccine development, gene therapy, and research in protein expression and functional genomics.

The primary types of mRNA synthesis services include mRNA vaccine synthesis and mRNA drug synthesis. mRNA vaccine synthesis refers to the laboratory process of generating mRNA sequences that guide cells to produce a specific protein, which triggers an immune response to combat infectious diseases. These services support several application areas such as vaccine development, therapeutic development, research and development, and diagnostics. The end-users of these services include pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations (CROs).

The mRNA synthesis service market research report is one of a series of new reports from The Business Research Company that provides mRNA synthesis service market statistics, including the mRNA synthesis service industry global market size, regional shares, competitors with the mRNA synthesis service market share, detailed mRNA synthesis service market segments, market trends, and opportunities, and any further data you may need to thrive in the mRNA synthesis service industry. This mRNA synthesis service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mRNA synthesis service market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.99 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. Growth during this historical period was driven by the rising demand for personalized medicine and gene therapies, the expansion of clinical trials, increased prevalence of infectious diseases, heightened investment in biotechnology, and an intensified focus on vaccine development.

The mRNA synthesis service market size is expected to see strong growth in the next few years. It will grow to $7.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. This anticipated growth is attributed to the increasing use of mRNA therapies, broader applications of mRNA technology, heightened focus on mRNA treatments for autoimmune diseases, sustained demand for mRNA-based vaccines, and rising need for custom mRNA synthesis solutions. Notable trends expected during this period include innovations in RNA polymerase enzyme engineering, development of next-generation mRNA vaccines, automation in mRNA manufacturing, personalized mRNA therapeutics, and the integration of AI and machine learning in mRNA design.

The increasing focus on personalized medicine is expected to propel the growth of the mRNA synthesis service market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to an individual's genetic makeup, lifestyle, and environment. This approach is gaining momentum due to advancements in genomic sequencing, which allow for more precise identification of individual genetic variations linked to disease and treatment response. mRNA synthesis services support the growing emphasis on personalized medicine by enabling the rapid and precise production of mRNA-based therapies tailored to an individual's genetic profile, resulting in more effective and targeted treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments in 2023 for patients with rare diseases, up from 6 in 2022. Among these, seven were cancer drugs, and three addressed other diseases and conditions. As such, the increasing focus on personalized medicine is driving the expansion of the mRNA synthesis service market.

Major companies operating in the mRNA synthesis service market are focusing on developing innovative solutions, such as RNA polymerase innovations, to improve the efficiency, yield, and safety of mRNA synthesis. RNA polymerase innovations involve the development of advanced enzymes that enhance the transcription process, reduce side effects like double-stranded RNA formation, and improve the overall quality of mRNA used in vaccines and therapeutics. For instance, in March 2025, Primrose Bio Inc., a US-based biotechnology company, introduced Prima RNApols to enhance the efficiency and scalability of mRNA synthesis. This enzyme offers enhanced processivity and high-fidelity transcription, enabling the production of longer and more stable mRNA strands with lower error rates. Its robust performance in in vitro transcription systems minimizes impurities and increases yield, providing a reliable and scalable solution for companies developing mRNA-based drugs. This innovation holds particular significance in personalized medicine, where accurate and efficient mRNA synthesis is critical.

In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. This acquisition is aimed at strengthening Novo Holdings' position in the life sciences sector by boosting its capabilities in drug development and supply while promoting sustainable value creation through an engaged ownership model. Catalent Inc., a US-based company, specializes in mRNA synthesis services for therapeutics and vaccines.

Major players in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, and APExBIO Technology LLC.

North America was the largest region in the m-RNA synthesis service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mRNA synthesis service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mRNA synthesis service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mRNA synthesis service market consists of revenues earned by entities by providing services such as template DNA preparation, codon optimization, stability and storage testing, and regulatory support for clinical applications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

m-RNA Synthesis Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on m-rna synthesis service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for m-rna synthesis service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The m-rna synthesis service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: mRNA Vaccine Synthesis; mRNA Drug Synthesis
• 2) By Application Area: Vaccine Development; Therapeutic Development; Research and Development; Diagnostics
• 3) By End-user Industry: Pharmaceutical Companies; Biotechnology Firms; Academic And Research Institutions; Contract Research Organizations (CROs)
• Subsegments:
• 1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines; Cancer Vaccines; Personalized Vaccines
• 2) By mRNA Drug Synthesis: Protein Replacement Therapies; Gene Editing Therapeutics; Cell Therapy Support
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; AGC Biologics Inc.; Eurofins Scientific SE; Lonza Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. m-RNA Synthesis Service Market Characteristics

3. m-RNA Synthesis Service Market Trends And Strategies

4. m-RNA Synthesis Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global m-RNA Synthesis Service Growth Analysis And Strategic Analysis Framework

• 5.1. Global m-RNA Synthesis Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global m-RNA Synthesis Service Market Growth Rate Analysis
• 5.4. Global m-RNA Synthesis Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global m-RNA Synthesis Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global m-RNA Synthesis Service Total Addressable Market (TAM)

6. m-RNA Synthesis Service Market Segmentation

• 6.1. Global m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• mRNA Vaccine Synthesis
• mRNA Drug Synthesis
• 6.2. Global m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccine Development
• Therapeutic Development
• Research and Development
• Diagnostics
• 6.3. Global m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Firms
• Academic And Research Institutions
• Contract Research Organizations (CROs)
• 6.4. Global m-RNA Synthesis Service Market, Sub-Segmentation Of mRNA Vaccine Synthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Vaccines
• Cancer Vaccines
• Personalized Vaccines
• 6.5. Global m-RNA Synthesis Service Market, Sub-Segmentation Of mRNA Drug Synthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Replacement Therapies
• Gene Editing Therapeutics
• Cell Therapy Support

7. m-RNA Synthesis Service Market Regional And Country Analysis

• 7.1. Global m-RNA Synthesis Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global m-RNA Synthesis Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific m-RNA Synthesis Service Market

• 8.1. Asia-Pacific m-RNA Synthesis Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China m-RNA Synthesis Service Market

• 9.1. China m-RNA Synthesis Service Market Overview
• 9.2. China m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India m-RNA Synthesis Service Market

• 10.1. India m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan m-RNA Synthesis Service Market

• 11.1. Japan m-RNA Synthesis Service Market Overview
• 11.2. Japan m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia m-RNA Synthesis Service Market

• 12.1. Australia m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia m-RNA Synthesis Service Market

• 13.1. Indonesia m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea m-RNA Synthesis Service Market

• 14.1. South Korea m-RNA Synthesis Service Market Overview
• 14.2. South Korea m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe m-RNA Synthesis Service Market

• 15.1. Western Europe m-RNA Synthesis Service Market Overview
• 15.2. Western Europe m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK m-RNA Synthesis Service Market

• 16.1. UK m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany m-RNA Synthesis Service Market

• 17.1. Germany m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France m-RNA Synthesis Service Market

• 18.1. France m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy m-RNA Synthesis Service Market

• 19.1. Italy m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain m-RNA Synthesis Service Market

• 20.1. Spain m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe m-RNA Synthesis Service Market

• 21.1. Eastern Europe m-RNA Synthesis Service Market Overview
• 21.2. Eastern Europe m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia m-RNA Synthesis Service Market

• 22.1. Russia m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America m-RNA Synthesis Service Market

• 23.1. North America m-RNA Synthesis Service Market Overview
• 23.2. North America m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA m-RNA Synthesis Service Market

• 24.1. USA m-RNA Synthesis Service Market Overview
• 24.2. USA m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada m-RNA Synthesis Service Market

• 25.1. Canada m-RNA Synthesis Service Market Overview
• 25.2. Canada m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America m-RNA Synthesis Service Market

• 26.1. South America m-RNA Synthesis Service Market Overview
• 26.2. South America m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil m-RNA Synthesis Service Market

• 27.1. Brazil m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East m-RNA Synthesis Service Market

• 28.1. Middle East m-RNA Synthesis Service Market Overview
• 28.2. Middle East m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa m-RNA Synthesis Service Market

• 29.1. Africa m-RNA Synthesis Service Market Overview
• 29.2. Africa m-RNA Synthesis Service Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa m-RNA Synthesis Service Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa m-RNA Synthesis Service Market, Segmentation By End-user Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. m-RNA Synthesis Service Market Competitive Landscape And Company Profiles

• 30.1. m-RNA Synthesis Service Market Competitive Landscape
• 30.2. m-RNA Synthesis Service Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AGC Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. m-RNA Synthesis Service Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Samsung Biologics Co. Ltd.
• 31.3. WuXi Biologics (Cayman) Inc.
• 31.4. GenScript Biotech Corporation
• 31.5. Azenta Inc.
• 31.6. Genewiz Inc.
• 31.7. New England Biolabs Inc.
• 31.8. TransGen Biotech Co. Ltd.
• 31.9. Creative Biolabs Inc.
• 31.10. Bioneer Corporation
• 31.11. Aldevron LLC
• 31.12. eTheRNA immunotherapies NV
• 31.13. Bio-Synthesis Inc.
• 31.14. TriLink BioTechnologies LLC
• 31.15. APExBIO Technology LLC

32. Global m-RNA Synthesis Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The m-RNA Synthesis Service Market

34. Recent Developments In The m-RNA Synthesis Service Market

35. m-RNA Synthesis Service Market High Potential Countries, Segments and Strategies

• 35.1 m-RNA Synthesis Service Market In 2029 - Countries Offering Most New Opportunities
• 35.2 m-RNA Synthesis Service Market In 2029 - Segments Offering Most New Opportunities
• 35.3 m-RNA Synthesis Service Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer